⚠️ Small Study / Early Comparative Evidence
Authors documented an 82-year-old woman with dementia, type 2 diabetes, and reduced mobility who presented with a 12.2 cm sigmoid and rectal fecaloma unresponsive to polyethylene glycol, senna, mineral oil, and sodium phosphate enemas. Two 1000 mL Classic Coca-Cola enemas produced 50% size reduction after the first administration and full symptom resolution.
Clinical Considerations
- Conservative management failed over 12 hospital days; first Coca-Cola enema achieved 50% fecaloma reduction within 24 hours on repeat CT
- Mechanism attributed to acidity (pH ~2.5), sodium bicarbonate content, and CO₂ release extrapolated from phytobezoar dissolution
- Published literature includes fewer than a dozen case reports, all uncontrolled and anecdotal, with no standardized protocols
- Theoretical concerns include mucosal injury, electrolyte disturbance, and systemic caffeine absorption, though none reported in existing cases
Practice Applications
- Consider Coca-Cola enema as adjunctive option for refractory fecaloma before endoscopic or surgical escalation
- Recognize the evidence base as anecdotal and hypothesis-generating, not standard of care
- Monitor electrolytes, hemodynamics, and abdominal status during and after administration
- Avoid routine clinical adoption absent prospective data on safety, dosing, and dwell time
More in Gastroenterology
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS